Kondo Nobuyuki Department
Specialty Division
, Clinical Medicine Seminars
Specialty Division
Thoracic Oncology, Clinical Medicine Seminars
Position
■ Journal
1.
Original article
Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung. 2014/02
2.
Original article
Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer. 2014/06
3.
Original article
Circulating tumor cells (CTCs) in malignant pleural mesothelioma (MPM). 2014/12
4.
Case report
Gene Mutation Analysis in Determining Late Recurrence of Adenocarcinoma of the Lung. 2015/08
5.
Original article
A Multicenter Feasibility Study of EBUS-TBNA for Potentially Operable Non-Small Cell Lung Cancer: The JMTO LC07-02 Study (UMIN000001280). 2016
6.
Case report
Successful surgical treatment for infectious giant bullae with mediastinal shift: A case report 2016
7.
Case report
Circulating Tumor Cell Count Can Be a Useful Prognostic Factor in Lung Resection via Cardiopulmonary Bypass 2017/01
8.
Original article
Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer. 2018/01
9.
Original article
The clinical value of circulating tumour cells (CTCs) in patients undergoing pulmonary metastasectomy for metastatic colorectal cancer. 2018/03
10.
Original article
Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma. 2019/01
11.
Original article
The mTOR Signaling Pathway Is Associated With the Prognosis of Malignant Pleural Mesothelioma After Multimodality Therapy. 2019/11
12.
Original article
Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma. 2020/08
13.
Original article
Clinicopathological features of radiological early malignant pleural mesothelioma with no apparent tumor or pleural thickening. 2021/01
14.
Original article
Quality of life and lung function after pleurectomy/decortication for malignant pleural mesothelioma. 2021/10
15.
Original article
Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma. 2022/09
Less invasive techniques and learning curve effects improve the outcome after extrapleural pneumonectomy for malignant pleural mesothelioma 2013/05
2.
Combination efficacy of m TOR and MEK inhibitor in malignant pleural mesothelioma(MPM) 2013/05/31
3.
Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer 2013/10/07
4.
Activation of mTOR signal pathway is associated with prolonged survival in malignant pleural mesothelioma patients 2013/10/28
5.
Association of activation of mTOR and MAPK signal pathway is associated with prolonged survival in parient with malignant pleural mesothelioma 2014/05/30
6.
Blood tests in malignant pleural mesothelioma (MPM). 2014/05/30
7.
Post-recurrence additional chemotherapy is feasible and effective in patients undergoing extrapleural pneumonectomy for malignant pleural mesothelioma 2014/09/29
8.
Diagnostic total parietal pleurectomy for pathologically-undetermined radiological/thoracoscopis TO malignant pleural mesothelioma. 2014/10/22
9.
Early results of consecutive 27 patients who underwent pleurectomy / decortication for malignant pleutral mesothelioma 2014/10/22
10.
Postoperative chemotherapy after pleurectomy/decortication for malignant pleural mesothelioma 2014/10/22
11.
The incidence and risk factors of part site seeding in MPM patients undergoing radical surgery 2014/10/22
12.
Small cell mesothelioma undergone multimodality therapy, report of a case 2014/10/23
13.
Induction Chemotherapy Followed by Surgery for Malignant Pleural Mesothelioma 2016/05/03
14.
The Analysis of the Recurrence of the Patients Who Underwent Surgical Resection for Malignant Pleural Mesothelioma 2016/05/03
15.
Integrative genomic analysis of 243 malignant pleural mesothelioma 2017/09/29